retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide The power of three: Retatrutide's role in modern obesity and diabetes therapy Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

A systematic search of PubMed, Scopus, and Web of Science was conducted up to December 2024 according to PRISMA guidelines

Compare early results with Wegovy and Mounjaro.

GLP-1 RAs have been shown to result in increased residual gastric contents (RGCs) in patients undergoing EGDs and poor Boston Bowel Preparation Scores (BBPSs) in those undergoing colonoscopies

IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits

GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss